Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 70


Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.

Plantinga LC, Lim SS, Patzer RE, Pastan SO, Drenkard C.

BMC Nephrol. 2016 Jul 7;17(1):64. doi: 10.1186/s12882-016-0274-y.


Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry.

Plantinga LC, Drenkard C, Pastan SO, Lim SS.

Lupus Sci Med. 2016 Jan 22;3(1):e000132. doi: 10.1136/lupus-2015-000132. eCollection 2016.


Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia.

Patzer RE, Plantinga LC, Paul S, Gander J, Krisher J, Sauls L, Gibney EM, Mulloy L, Pastan SO.

JAMA. 2015 Aug 11;314(6):582-94. doi: 10.1001/jama.2015.8897.


Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.

Plantinga LC, Patzer RE, Drenkard C, Pastan SO, Cobb J, McClellan W, Lim SS.

BMC Nephrol. 2015 Mar 29;16:39. doi: 10.1186/s12882-015-0037-1.


Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Drenkard C, Patzer RE, Klein M, Kramer MR, Pastan S, Lim SS, McClellan WM.

Arthritis Rheumatol. 2015 Mar;67(3):761-72. doi: 10.1002/art.38983.


Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Patzer RE, Drenkard C, Kramer MR, Klein M, Lim SS, McClellan WM, Pastan SO.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):571-81. doi: 10.1002/acr.22482.


Biomarkers of vascular calcification and mortality in patients with ESRD.

Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS.

Clin J Am Soc Nephrol. 2014 Apr;9(4):745-55. doi: 10.2215/CJN.05450513. Epub 2014 Jan 23.


Pre-end-stage renal disease care not associated with dialysis facility neighborhood poverty in the United States.

Plantinga LC, Kim M, Goetz M, Kleinbaum DG, McClellan W, Patzer RE.

Am J Nephrol. 2014;39(1):50-8. doi: 10.1159/000358067. Epub 2014 Jan 15.


A public health perspective on CKD and obesity.

McClellan WM, Plantinga LC.

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv37-42. doi: 10.1093/ndt/gft030. Review.


Estimating prevalence of CKD stages 3-5 using health system data.

Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, Powe NR, Saran R; CDC CKD Surveillance System.

Am J Kidney Dis. 2013 Jun;61(6):930-8. doi: 10.1053/j.ajkd.2013.01.018. Epub 2013 Mar 13.


Americans' use of dietary supplements that are potentially harmful in CKD.

Grubbs V, Plantinga LC, Tuot DS, Hedgeman E, Saran R, Saydah S, Rolka D, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team.

Am J Kidney Dis. 2013 May;61(5):739-47. doi: 10.1053/j.ajkd.2012.12.018. Epub 2013 Feb 14.


Healthy behaviors, risk factor control and awareness of chronic kidney disease.

Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu CY, Warnock DG, Gutiérrez OM, Safford M, Powe NR, McClellan WM; REGARDS Investigators.

Am J Nephrol. 2013;37(2):135-43. doi: 10.1159/000346712. Epub 2013 Jan 31.


Socio-economic impact in CKD.

Plantinga LC.

Nephrol Ther. 2013 Feb;9(1):1-7. doi: 10.1016/j.nephro.2012.07.361. Epub 2013 Jan 12. Review.


Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.

Shafi T, Sozio SM, Plantinga LC, Jaar BG, Kim ET, Parekh RS, Steffes MW, Powe NR, Coresh J, Selvin E.

Diabetes Care. 2013 Jun;36(6):1522-33. doi: 10.2337/dc12-1896. Epub 2012 Dec 18.


Medicare immunosuppressant coverage and access to kidney transplantation: a retrospective national cohort study.

Grubbs V, Plantinga LC, Vittinghoff E, O'Hare AM, Dudley RA.

BMC Health Serv Res. 2012 Aug 16;12:254. doi: 10.1186/1472-6963-12-254.


Serum β-trace protein and risk of mortality in incident hemodialysis patients.

Shafi T, Parekh RS, Jaar BG, Plantinga LC, Oberai PC, Eckfeldt JH, Levey AS, Powe NR, Coresh J.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1435-45. doi: 10.2215/CJN.02240312. Epub 2012 Jun 28.


Chronic kidney disease identification in a high-risk urban population: does automated eGFR reporting make a difference?

Plantinga LC, Tuot DS, Grubbs V, Hsu CY, Powe NR.

J Urban Health. 2012 Dec;89(6):965-76. doi: 10.1007/s11524-012-9726-2.


Chronic kidney disease and use of dental services in a United States public healthcare system: a retrospective cohort study.

Grubbs V, Plantinga LC, Tuot DS, Powe NR.

BMC Nephrol. 2012 Apr 2;13:16. doi: 10.1186/1471-2369-13-16.


Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?

Tuot DS, Plantinga LC, Hsu CY, Powe NR.

Am J Nephrol. 2012;35(2):191-7. doi: 10.1159/000335935. Epub 2012 Jan 27.


Lower socioeconomic status and disability among US adults with chronic kidney disease, 1999-2008.

Plantinga LC, Johansen KL, Schillinger D, Powe NR.

Prev Chronic Dis. 2012;9:E12. Epub 2011 Dec 15.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk